InspireMD (NYSE: NSPR) announced that the FDA has approved the Company's submitted IDE amendment for certain manufacturing process changes to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE